HABA to Market New Supplement in February.Tokyo, Japan, Jan 23, 2006 - (JCN JCN Japan Corporate News JCN Journal of Cognitive Neuroscience JCN Journal of Cardiovascular Nursing JCN Journal of Christian Nursing JCN Job Control Number JCN Journal of Child Neurology JCN joint communications network (US DoD) ) - HABA HABA 2-(4'-hydroxyazobenzene) benzoic acid. Laboratories announced on January 20 that PRIME HABA Products, a joint venture the company set up with PRIME, will begin marketing a new supplement, Walk Suppli, on February 9. The new product, which contains chondroitin chondroitin (k  n·droiˑ·tin),n , glucosamine glucosamine /glu·co·sa·mine/ (gloo-ko´sah-men) an amino derivative of glucose, occurring in glycosaminoglycans and a variety of complex polysaccharides such as blood group substances. , hyaluronic acid, vitamin C and methylsulfonylmethane, helps alleviate joint pain. A 180-tablet bottle will sell for 3,990 yen ($34). The product will be available at PRIME's mail-order service via the Internet and TV. Copyright [c] 2006 Japan Corporate News Network. All rights reserved. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion